Medication info

Raviwon Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
Round white film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201405828 · Approved 2014.12.09

This product's status changed to Expired on 2024.12.09. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.) and prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to concomitant therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for prevention of gastric and duodenal ulcers during long-term NSAID use. Diseases caused by NSAID use usually heal within 4 weeks, and generally within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe gastroesophageal reflux disease, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily, and increase the dose if necessary. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.) and prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs
View approved original text

This medication is used for the treatment of gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective in preventing ulcers after surgery and ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs). It is also used to prevent Mendelson's syndrome prior to anesthesia. This medication helps improve various gastrointestinal-related diseases and symptoms.

How to take

Adult dose

○ Adults Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to concomitant therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for prevention of gastric and duodenal ulcers during long-term NSAID use. Diseases caused by NSAID use usually heal within 4 weeks, and generally within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe gastroesophageal reflux disease, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily, and increase the dose if necessary. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those allergic to this medication or its components. It should not be administered to individuals with a history of acute porphyria as it may induce seizures. It is also advisable to avoid use in patients with impaired renal function, those who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants, and neonates. Patients on a potassium-restricted diet should also exercise caution. Patients with liver dysfunction, a history of drug allergies, the elderly, and patients with a history of renal impairment should be careful when using this medication. Regular monitoring is particularly necessary for the elderly and patients with a history of gastric ulcers when taking it in conjunction with NSAIDs. It may mask the symptoms of gastric cancer, so gastric ulcer patients or those with new dyspeptic symptoms over middle age should be administered after confirming malignancy. Patients with Helicobacter pylori infection require eradication therapy. Special caution is needed when administering to critically ill patients, those with hypophosphatemia, and patients with dysphagia. This medication may rarely cause serious allergic reactions such as anaphylactic shock, so if any unusual symptoms occur during administration, the medication should be discontinued immediately and a healthcare professional should be consulted. Skin rash, hives, and respiratory distress are other signs of hypersensitivity that should be noted. Various side effects such as blood cell count reduction, liver dysfunction, arrhythmia, gastrointestinal disturbances, dizziness, drowsiness, confusion, agitation, insomnia, headache, heaviness, malaise, anxiety, depression, hallucinations, blurred vision, involuntary movement disorders, gynecomastia, excessive milk secretion, erectile dysfunction, decreased libido, joint pain, muscle pain, skin itching, stomatitis, and hair loss have been reported. Particularly in patients with reduced renal function or the elderly, neurological symptoms may appear more readily, necessitating careful observation. It is advisable not to use this medication for extended periods, and if no therapeutic effect is observed, switching to another medication is recommended. Caution should also be exercised in the elderly, patients with chronic lung disease, diabetes, and those with weakened immunity, as the risk of pneumonia may increase. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so particularly when taking anticoagulants like warfarin, blood tests should be conducted to closely monitor the condition. When used in combination with certain antibiotics or antiepileptic drugs, absorption may be affected, so it is advisable to allow sufficient intervals between dosages. It is safest not to use this medication during pregnancy or lactation, and safety has not been established in children, so its use is not recommended. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and in severe cases, removal by hemodialysis may be required. This medication reduces gastric acid secretion and can promote bacterial proliferation in the stomach; long-term administration may necessitate testing for eye health.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 51 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelodysplastic syndrome
  • bone marrow aplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal bleeding
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • seizures
  • agitation
  • insomnia
  • headache
  • feeling of heaviness in the head
  • illness perception
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movements
  • altered consciousness
  • myotonic spasms
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air exposure and is best kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage can maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Round white film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.